Cargando…
The prevalence of rheumatoid arthritis in Western Australia
BACKGROUND: Rheumatoid arthritis (RA) is the most common form of autoimmune arthritis, but the prevalence in Australia is unknown. We estimated RA period prevalence and identified factors associated with frequent RA hospitalisations, using linked administrative health and state-specific Australian P...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804946/ https://www.ncbi.nlm.nih.gov/pubmed/36585680 http://dx.doi.org/10.1186/s41927-022-00324-5 |
_version_ | 1784862230454468608 |
---|---|
author | Almutairi, Khalid Inderjeeth, Charles Preen, David B Keen, Helen Nossent, Johannes |
author_facet | Almutairi, Khalid Inderjeeth, Charles Preen, David B Keen, Helen Nossent, Johannes |
author_sort | Almutairi, Khalid |
collection | PubMed |
description | BACKGROUND: Rheumatoid arthritis (RA) is the most common form of autoimmune arthritis, but the prevalence in Australia is unknown. We estimated RA period prevalence and identified factors associated with frequent RA hospitalisations, using linked administrative health and state-specific Australian Pharmaceutical Benefits Scheme (PBS) datasets in Western Australia (WA) from 1995 to 2014. METHODS: This was a longitudinal population-based cohort study using two independent datasets to identify prevalent RA patients. RA prevalence was calculated per 1000 hospital separations and biological therapy users. RA patients were identified in the WA linked health dataset using ICD codes 714.0–714.9 and M05.00–M06.99. Dispensing data on biological therapy for RA were obtained from PBS records and converted to defined daily doses /1000 population/day. Multivariable logistic regression was used to analyse factors associated with frequent RA hospitalisations (> 2/year), controlling for sex, age, and geographic locations. Potential interactions were assessed using logistic regression in a stepwise approach. RESULTS: A total of 17,125 RA patients had 50,353 hospital separations between 1995 and 2014, averaging three hospitalisations per patient over 20 years. The RA period prevalence was 3.4 per 1000 separations (0.34%; 95% CI 0.33–0.34), while the RA period prevalence based on biological therapy use was 0.36% (95% CI 0.35–0.37). The corrected RA prevalence based on biological therapy usage was 0.36% (95% CI 0.35–0.37) for the 2005–2009 and increased to 0.72% (95% CI 0.70–0.74) in 2010–2014 period. Associated factors for frequent RA hospitalisations were being female [1.21 (95% CI 1.15–1.26)], aged 60–69 years [4.45 (95% CI 3.74–5.30)], living in rural areas [1.12 (95% CI 1.02–1.24)]. The odd ratio of interaction between these associated factors was 1.34 (95% CI 1.16–1.55). CONCLUSION: The minimal prevalence of RA in Western Australia is 0.34–0.36%, which falls within the literature range. Older female RA patients in rural were more likely to be hospitalised, suggesting unmet primary care for needs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00324-5. |
format | Online Article Text |
id | pubmed-9804946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98049462023-01-01 The prevalence of rheumatoid arthritis in Western Australia Almutairi, Khalid Inderjeeth, Charles Preen, David B Keen, Helen Nossent, Johannes BMC Rheumatol Research Article BACKGROUND: Rheumatoid arthritis (RA) is the most common form of autoimmune arthritis, but the prevalence in Australia is unknown. We estimated RA period prevalence and identified factors associated with frequent RA hospitalisations, using linked administrative health and state-specific Australian Pharmaceutical Benefits Scheme (PBS) datasets in Western Australia (WA) from 1995 to 2014. METHODS: This was a longitudinal population-based cohort study using two independent datasets to identify prevalent RA patients. RA prevalence was calculated per 1000 hospital separations and biological therapy users. RA patients were identified in the WA linked health dataset using ICD codes 714.0–714.9 and M05.00–M06.99. Dispensing data on biological therapy for RA were obtained from PBS records and converted to defined daily doses /1000 population/day. Multivariable logistic regression was used to analyse factors associated with frequent RA hospitalisations (> 2/year), controlling for sex, age, and geographic locations. Potential interactions were assessed using logistic regression in a stepwise approach. RESULTS: A total of 17,125 RA patients had 50,353 hospital separations between 1995 and 2014, averaging three hospitalisations per patient over 20 years. The RA period prevalence was 3.4 per 1000 separations (0.34%; 95% CI 0.33–0.34), while the RA period prevalence based on biological therapy use was 0.36% (95% CI 0.35–0.37). The corrected RA prevalence based on biological therapy usage was 0.36% (95% CI 0.35–0.37) for the 2005–2009 and increased to 0.72% (95% CI 0.70–0.74) in 2010–2014 period. Associated factors for frequent RA hospitalisations were being female [1.21 (95% CI 1.15–1.26)], aged 60–69 years [4.45 (95% CI 3.74–5.30)], living in rural areas [1.12 (95% CI 1.02–1.24)]. The odd ratio of interaction between these associated factors was 1.34 (95% CI 1.16–1.55). CONCLUSION: The minimal prevalence of RA in Western Australia is 0.34–0.36%, which falls within the literature range. Older female RA patients in rural were more likely to be hospitalised, suggesting unmet primary care for needs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41927-022-00324-5. BioMed Central 2022-12-31 /pmc/articles/PMC9804946/ /pubmed/36585680 http://dx.doi.org/10.1186/s41927-022-00324-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Almutairi, Khalid Inderjeeth, Charles Preen, David B Keen, Helen Nossent, Johannes The prevalence of rheumatoid arthritis in Western Australia |
title | The prevalence of rheumatoid arthritis in Western Australia |
title_full | The prevalence of rheumatoid arthritis in Western Australia |
title_fullStr | The prevalence of rheumatoid arthritis in Western Australia |
title_full_unstemmed | The prevalence of rheumatoid arthritis in Western Australia |
title_short | The prevalence of rheumatoid arthritis in Western Australia |
title_sort | prevalence of rheumatoid arthritis in western australia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804946/ https://www.ncbi.nlm.nih.gov/pubmed/36585680 http://dx.doi.org/10.1186/s41927-022-00324-5 |
work_keys_str_mv | AT almutairikhalid theprevalenceofrheumatoidarthritisinwesternaustralia AT inderjeethcharles theprevalenceofrheumatoidarthritisinwesternaustralia AT preendavidb theprevalenceofrheumatoidarthritisinwesternaustralia AT keenhelen theprevalenceofrheumatoidarthritisinwesternaustralia AT nossentjohannes theprevalenceofrheumatoidarthritisinwesternaustralia AT almutairikhalid prevalenceofrheumatoidarthritisinwesternaustralia AT inderjeethcharles prevalenceofrheumatoidarthritisinwesternaustralia AT preendavidb prevalenceofrheumatoidarthritisinwesternaustralia AT keenhelen prevalenceofrheumatoidarthritisinwesternaustralia AT nossentjohannes prevalenceofrheumatoidarthritisinwesternaustralia |